These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20050391)

  • 1. Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings.
    Menzies NA; Homsy J; Chang Pitter JY; Pitter C; Mermin J; Downing R; Finkbeiner T; Obonyo J; Kekitiinwa A; Tappero J; Blandford JM
    Pediatr Infect Dis J; 2009 Sep; 28(9):819-25. PubMed ID: 20050391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and implementation challenges of a quality assured HIV infant diagnosis program in Nigeria using dried blood spots and DNA polymerase chain reaction.
    Audu R; Onwuamah C; Salu O; Okwuraiwe A; Ou CY; Bolu O; Bond KB; Diallo K; Lu L; Jelpe T; Okoye M; Ngige E; Vertefeuille J
    AIDS Res Hum Retroviruses; 2015 Apr; 31(4):433-8. PubMed ID: 25381805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions.
    Ciaranello AL; Park JE; Ramirez-Avila L; Freedberg KA; Walensky RP; Leroy V
    BMC Med; 2011 May; 9():59. PubMed ID: 21599888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency.
    Francke JA; Penazzato M; Hou T; Abrams EJ; MacLean RL; Myer L; Walensky RP; Leroy V; Weinstein MC; Parker RA; Freedberg KA; Ciaranello A
    J Infect Dis; 2016 Nov; 214(9):1319-1328. PubMed ID: 27540110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost-effectiveness of scaling-up rapid point-of-care testing for early infant diagnosis of HIV in southern Zambia.
    De Broucker G; Salvatore PP; Mutembo S; Moyo N; Mutanga JN; Thuma PE; Moss WJ; Sutcliffe CG
    PLoS One; 2021; 16(3):e0248217. PubMed ID: 33690733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility.
    Kankasa C; Carter RJ; Briggs N; Bulterys M; Chama E; Cooper ER; Costa C; Spielman E; Katepa-Bwalya M; M'soka T; Ou CY; Abrams EJ
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):202-8. PubMed ID: 19504732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed Opportunities for HIV Confirmatory Testing Using an Institutional Testing Algorithm Without Reflex to HIV Nucleic Acid Testing.
    Caster L; Paetz OR; Sayles H; Fey PD; Bares SH
    Sex Transm Dis; 2024 Aug; 51(8):545-547. PubMed ID: 38989902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative algorithms for human immunodeficiency virus infection diagnosis using tests that are licensed in the United States.
    Owen SM; Yang C; Spira T; Ou CY; Pau CP; Parekh BS; Candal D; Kuehl D; Kennedy MS; Rudolph D; Luo W; Delatorre N; Masciotra S; Kalish ML; Cowart F; Barnett T; Lal R; McDougal JS
    J Clin Microbiol; 2008 May; 46(5):1588-95. PubMed ID: 18322061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences among diagnostic testing algorithms in the time from HIV diagnosis to care.
    Peruski AH; Wu B; Selik RM
    J Clin Virol; 2019 Jul; 116():18-22. PubMed ID: 31039483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocytes among HIV-infected and -uninfected infants: CD4/CD8 ratio as a potential tool in diagnosis of infection in infants under the age of 2 years.
    Zijenah LS; Katzenstein DA; Nathoo KJ; Rusakaniko S; Tobaiwa O; Gwanzura C; Bikoue A; Nhembe M; Matibe P; Janossy G
    J Transl Med; 2005 Feb; 3(1):6. PubMed ID: 15683549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in Clinical Manifestations of Acute and Early HIV-1 Infection between HIV-1 Subtypes in African Women.
    Lemonovich TL; Watkins RR; Morrison CS; Kwok C; Chipato T; Musoke R; Arts EJ; Nankya I; Salata RA
    J Int Assoc Provid AIDS Care; 2015; 14(5):415-22. PubMed ID: 24106054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costing and cost-effectiveness of Cepheid Xpert HIV -1 Qual Assay using whole blood protocol versus PCR by Abbott Systems in Malawi.
    Nyirenda-Nyang'wa M; Manthalu G; Arnold M; Nkhoma D; Hosseinipour MC; Chagomerana M; Chibwe P; Mortimer K; Kennedy N; Fairley D; Mwapasa V; Msefula C; Mwandumba HC; Chinkhumba J; Klein N; Alber D; Obasi A
    J Glob Health Econ Policy; 2022; 2():. PubMed ID: 37711180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Diagnosis of HIV Infection in Infants and Children.
    Abdollahi A; Saffar H
    Iran J Pathol; 2016; 11(2):89-96. PubMed ID: 27499768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction-driven pooled testing methods: Application to HIV treatment monitoring in Rakai, Uganda.
    Brand A; May S; Hughes JP; Nakigozi G; Reynolds SJ; Gabriel EE
    Stat Med; 2021 Aug; 40(19):4185-4199. PubMed ID: 34046930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing time to new HIV diagnosis: time for change in the HIV diagnostic algorithm?
    Moso MA; Williams E; Singh KP; Lewin SR; Williamson DA
    Pathology; 2023 Aug; 55(5):740-742. PubMed ID: 36842873
    [No Abstract]   [Full Text] [Related]  

  • 16. High Prevalence of Unconfirmed Positive HIV PCR Test Results among African Infants with HIV Exposure in the International epidemiology Databases to Evaluate AIDS (IeDEA) Consortium.
    Carlucci JG; Huntington T; Technau KG; Yotebieng M; Leroy V; Anderson K; Amorissani-Folquet M; Wools-Kaloustian K; Edmonds A
    Clin Infect Dis; 2024 May; ():. PubMed ID: 38742844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment HIV drug resistance testing cost-effectiveness.
    van de Vijver DA; Nichols BE
    EClinicalMedicine; 2020 May; 22():100381. PubMed ID: 32478315
    [No Abstract]   [Full Text] [Related]  

  • 18. Modeling the cost-effectiveness of point-of-care platforms for infant diagnosis of HIV in sub-Saharan African countries.
    Salvatore PP; de Broucker G; Vojnov L; Moss WJ; Dowdy DW; Sutcliffe CG
    AIDS; 2021 Feb; 35(2):287-297. PubMed ID: 33394672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for quality assurance systems to save costs and lives: the case of early infant diagnosis of HIV.
    Terris-Prestholt F; Boeras D; Ong JJ; Torres-Rueda S; Cassim N; Mbengue MAS; Mboup S; Mwau M; Munemo E; Nyegenye W; Odhiambo CO; Dabula P; Sandstrom P; Sarr M; Simbi R; Stevens W; Tucker JD; Vickerman P; Ciaranello A; Peeling RW
    Trop Med Int Health; 2020 Oct; 25(10):1235-1245. PubMed ID: 32737914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review.
    Elsbernd K; Emmert-Fees KMF; Erbe A; Ottobrino V; Kroidl A; Bärnighausen T; Geisler BP; Kohler S
    Infect Dis Poverty; 2022 Jul; 11(1):82. PubMed ID: 35841117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.